Clinical Trial Update: Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of Fluorodeoxyglucose in PET-CT imaging for histiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Histiocytosis

Drugs mentioned

• Fluorodeoxyglucose (Fluorodeoxyglucose)

Snippet

Sponsor: Anna Raciborska | Conditions: Histiocytosis | Phase 3 | Status: RECRUITING